September 13, 2023 MGB EM Faculty Development Series: Updates in Emergency Medicine 2023-2024: Dental Training - Archived

Description

This activity provides on-demand archived lectures from the MGB EM Faculty Development Series: Updates in Emergency Medicine 2023-2024 series. The Emergency Medicine Faculty (Attending physicians) at Mass General Brigham are expected to achieve and maintain American Board of Emergency Medicine clinical practice standards. Once a physician has attained Board Eligibility then Certification, faculty need to continually maintain knowledge of not only current practice guidelines in the specialty, but also understand the ever-changing operational and regulatory environments in which we practice.  This educational series is designed to provide the most current information to patients and learners/trainees in a broad range of areas including but not limited to clinical practice, health policy, patient safety, professional development, business practices, and compliance/regulatory requirements.

Course Directors:
Josh Goldstein MD PhD & Tim Erickson MD & Melisa Lai-Becker MD

For questions regarding the registration process, please contact Mass General Brigham Office of Continuing Professional Development at partnerscpd@partners.org.

You may print individual certificates throughout the year; your cumulative list of sessions attended is accessible on your transcript.

Target Audience

This activity is intended for MGB Enterprise Department of Emergency Medicine Attending Physicians Faculty

Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Discuss ED assessment, diagnostics and initial management of patients with acute injuries, diseases or medical conditions by application of evidence-based therapies
  2. Demonstrate understanding of calling appropriate and timely consults for patients with acute injuries, diseases, or medical conditions; and apply appropriate interdisciplinary communication and coordination of care
  3. List and describe current regulations and recent regulatory changes affecting Emergency/Acute care practice with anticipated effects on ED patient characteristics/volume/census/flow
  4. Differentiate and discuss indications for admission/transfer to different levels of care
  5. Compose well-structured medical-decision-making documentation of encounters that reflect the amount of work put into evaluation and management of an Emergency Department patient

Additional Information

Provided by: 

Provided by Mass General Brigham

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
07/05/2023
Course expires: 
06/30/2025
Cost:
$0.00
Part of: 
MGB EM Faculty Development Series: Updates in Emergency Medicine 2023-2024: Archived
Mass General Brigham
MA 02145
United States

Course Directors

Josh Goldstein MD PhD
Vice Chair, Academic Affairs,
Massachusetts General Hospital

Tim Erickson MD
Vice Chair, Academic Affairs,
Brigham and Women’s Hospital

Melisa Lai-Becker MD
Deputy Chief, MGB Enterprise Emergency Medicine
Mass General Brigham
 

Faculty

Lama Alabdulaaly, BDS DMSc ABOMP
Alice Bukhman, MD
Da’Marcus Baymon, MD
Adaira Landry, MD

 

DISCLOSURE SUMMARY OF RELEVANT FINANCIAL RELATIONSHIPS

MITIGATION STRATEGIES
Mass General Brigham has implemented a process to mitigate relevant financial relationships for this continuing education (CE) activity to help ensure content objectivity, independence, fair balance and ensure that the content is aligned with the interest of the public. 

The following planners reported no relevant financial relationship with an ineligible company:
Tim Erickson MD
Melisa Lai-Becker MD

The following planners reported no relevant financial relationship with an ineligible company:
Josh Goldstein MD PhD
Consulting: Pfizer, Takeda, Octapharma, AstraZeneca, CSL Behring, NControl, Cayuga
Research: Pfizer, Takeda, Octapharma

The following speakers have reported no relevant financial relationships with an ineligible company:
Lama Alabdulaaly, BDS DMSc ABOMP
Alice Bukhman, MD
Da’Marcus Baymon, MD
Adaira Landry, MD

The following speakers have reported a relevant financial relationship with an ineligible company:
Josh Goldstein MD PhD
Consulting: Pfizer, Takeda, Octapharma, AstraZeneca, CSL Behring, NControl, Cayuga
Research: Pfizer, Takeda, Octapharma

 

ACCREDITATION

In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statements

AMA PRA Category 1 CreditTM
Mass General Brigham designates this live activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Price

Cost:
$0.00
Please login or register to take this course.